Literature DB >> 5056733

Metabolic responses to acute and chronic L-dopa administration in patients with parkinsonism.

C R Sirtori, P Bolme, D L Azarnoff.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 5056733     DOI: 10.1056/NEJM197210122871501

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  25 in total

Review 1.  Effects of drugs on glucose tolerance in non-insulin-dependent diabetics (Part II).

Authors:  S O'Byrne; J Feely
Journal:  Drugs       Date:  1990-08       Impact factor: 9.546

Review 2.  Minireview: Dopaminergic regulation of insulin secretion from the pancreatic islet.

Authors:  Alessandro Ustione; David W Piston; Paul E Harris
Journal:  Mol Endocrinol       Date:  2013-06-06

3.  Measures of striatal insulin resistance in a 6-hydroxydopamine model of Parkinson's disease.

Authors:  J K Morris; H Zhang; A A Gupte; G L Bomhoff; J A Stanford; P C Geiger
Journal:  Brain Res       Date:  2008-09-11       Impact factor: 3.252

4.  Effect of hypoglycaemia, TRH and levodopa on plasma growth hormone, prolactin, thyrotropin and cortisol in Parkinson's disease before and during therapy.

Authors:  H P Vogel; R Ketsche
Journal:  J Neurol       Date:  1986-06       Impact factor: 4.849

Review 5.  Parkinson's disease and levodopa. A five-year follow-up and review.

Authors:  C H Markham; L J Treciokas; S G Diamond
Journal:  West J Med       Date:  1974-09

6.  An extended clinical trial to compare levodopa and amantadine used as single drugs with both drugs used incombination in Parkinson's Disease.

Authors:  N Calaghan; M McIlroy; M O'Connor
Journal:  Ir J Med Sci       Date:  1974-03       Impact factor: 1.568

7.  The role of carbohydrate and oral agents in the treatment of diabetes mellitus.

Authors:  W D Odell
Journal:  Calif Med       Date:  1973-10

8.  Prolonged levodopa therapy.

Authors: 
Journal:  Br Med J       Date:  1973-02-17

9.  Influences of levodopa on adipose tissue and skeletal muscle metabolism in patients with idiopathic Parkinson's disease.

Authors:  Frauke Adams; Michael Boschmann; Elmar Lobsien; Andreas Kupsch; Axel Lipp; Gabriele Franke; Marie Charlotte Leisse; Juergen Janke; Simone Gottschalk; Joachim Spranger; Jens Jordan
Journal:  Eur J Clin Pharmacol       Date:  2008-07-30       Impact factor: 2.953

10.  Metabolic abnormalities and hypoleptinemia in α-synuclein A53T mutant mice.

Authors:  Sarah M Rothman; Kathleen J Griffioen; Kenneth W Fishbein; Richard G Spencer; Sokratis Makrogiannis; Wei-Na Cong; Bronwen Martin; Mark P Mattson
Journal:  Neurobiol Aging       Date:  2013-10-22       Impact factor: 4.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.